Disciplined Growth Investors Inc. MN Has $104.76 Million Stock Holdings in Core Laboratories Inc. (NYSE:CLB)

Disciplined Growth Investors Inc. MN boosted its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 26.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,653,591 shares of the oil and gas company's stock after acquiring an additional 1,192,871 shares during the period. Core Laboratories accounts for 2.0% of Disciplined Growth Investors Inc. MN's investment portfolio, making the stock its 24th biggest holding. Disciplined Growth Investors Inc. MN owned approximately 12.04% of Core Laboratories worth $104,761,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of CLB. Louisiana State Employees Retirement System boosted its holdings in Core Laboratories by 2.2% in the 2nd quarter. Louisiana State Employees Retirement System now owns 23,600 shares of the oil and gas company's stock valued at $479,000 after purchasing an additional 500 shares during the period. The Manufacturers Life Insurance Company raised its position in shares of Core Laboratories by 3.3% during the second quarter. The Manufacturers Life Insurance Company now owns 18,054 shares of the oil and gas company's stock valued at $366,000 after buying an additional 579 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Core Laboratories by 11.9% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company's stock valued at $114,000 after buying an additional 600 shares during the period. Oppenheimer Asset Management Inc. grew its position in Core Laboratories by 1.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 54,310 shares of the oil and gas company's stock worth $1,102,000 after buying an additional 758 shares in the last quarter. Finally, Signaturefd LLC increased its stake in Core Laboratories by 12.8% during the second quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company's stock valued at $137,000 after acquiring an additional 767 shares during the period. 97.81% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have commented on CLB shares. Citigroup reduced their price objective on Core Laboratories from $15.00 to $14.00 and set a "sell" rating for the company in a research report on Thursday, October 31st. StockNews.com raised Core Laboratories from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $17.00.

Core Laboratories Price Performance

NYSE CLB traded up $0.45 during trading on Tuesday, reaching $19.84. 119,012 shares of the company traded hands, compared to its average volume of 412,162. Core Laboratories Inc. has a 1-year low of $13.82 and a 1-year high of $25.13. The company has a market cap of $931.49 million, a price-to-earnings ratio of 29.78, a P/E/G ratio of 1.30 and a beta of 2.35. The stock's 50 day moving average price is $19.67 and its two-hundred day moving average price is $19.65. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.79 and a current ratio of 2.48.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.04. The firm had revenue of $134.40 million for the quarter, compared to analysts' expectations of $134.16 million. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. The business's revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.22 earnings per share. As a group, analysts anticipate that Core Laboratories Inc. will post 0.8 EPS for the current year.

Core Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were given a $0.01 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $0.04 dividend on an annualized basis and a yield of 0.20%. Core Laboratories's dividend payout ratio (DPR) is presently 6.15%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.